Morphic’s stock rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly in a cash deal valued at about $3.2 billion.
Source link
Eli Lilly to pay $3.2 billion in cash to buy this biotech with an IBD treatment
-
West virginia digital
- . July 8, 2024
